Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans
Abstract Background Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker cutoffs from immunoassays with low interlaboratory variability in diverse ethnic groups are necessary for their use in clinics and clinical trials. With lack of cutoffs from fully automated immunoassay platforms in dive...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2021-01-01
|
| シリーズ: | Alzheimer’s Research & Therapy |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s13195-020-00767-3 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
